Skip to main content
Clinical Trials/NCT01302717
NCT01302717
Withdrawn
N/A

Impact of Left Ventricular Pacing on Left Ventricular Systolic Function in High-risk Bradycardia Patients

Seoul National University Hospital2 sites in 1 countryApril 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Complete AV Block
Sponsor
Seoul National University Hospital
Locations
2
Primary Endpoint
Left ventricular ejection fraction (%) at 12 months
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

In this study, the investigators will examine whether left ventricular pacing is superior to right ventricular apical pacing in preventing deterioration of left ventricular systolic function and cardiac remodeling in patients with bradycardia with high risk for development of pacing-induced heart failure.

Detailed Description

In this prospective, we will randomly assign 98 patients who need permanent pacemaker due to complete atrioventricular block or sick sinus syndrome to receive left ventricular pacing (49 patients) or right ventricular apical pacing (49 patients). Patients will be paced with temporary pacemaker lead, and only those with paced QRS duration ≥185 ms will be enrolled. The primary endpoint is left ventricular ejection fraction measured by modified Simpson method at 12 months. The secondary end points include left ventricular systolic end-systolic and diastolic volume, LV strain, NYHA functional class, exercise performance (using treadmill test), quality of life (using SF-36v2), NT-proBNP at 12 months.

Registry
clinicaltrials.gov
Start Date
April 2010
End Date
December 31, 2019
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Seil Oh

Dr.

Seoul National University Hospital

Eligibility Criteria

Inclusion Criteria

  • Sinus-node dysfunction or bradycardia due to advanced atrioventricular block
  • Paced QRS duration ≥185 ms

Exclusion Criteria

  • Left ventricular ejection fraction \< 50 %
  • Acute coronary syndrome
  • If they had undergone percutaneous coronary intervention or coronary-artery bypass surgery within the previous 3 months
  • if they had a life expectancy of less than 1 year
  • if they had received a heart transplant

Outcomes

Primary Outcomes

Left ventricular ejection fraction (%) at 12 months

Time Frame: 12 months

Measured by modified Simpson's method

Secondary Outcomes

  • NYHA functional class(12 months)
  • NT-proBNP(12 months)
  • Left ventricular end-systolic volume (ml) at 12 months(12 months)
  • Functional capacity(12 months)
  • Left ventricular end-diastolic volume (ml) at 12 months(12 months)

Study Sites (2)

Loading locations...

Similar Trials